These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


458 related items for PubMed ID: 8648511

  • 1. Activating mutations of Gs protein in monostotic fibrous lesions of bone.
    Alman BA, Greel DA, Wolfe HJ.
    J Orthop Res; 1996 Mar; 14(2):311-5. PubMed ID: 8648511
    [Abstract] [Full Text] [Related]

  • 2. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.
    Marie PJ, de Pollak C, Chanson P, Lomri A.
    Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842
    [Abstract] [Full Text] [Related]

  • 3. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
    Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM.
    N Engl J Med; 1991 Dec 12; 325(24):1688-95. PubMed ID: 1944469
    [Abstract] [Full Text] [Related]

  • 4. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
    Hannon TS, Noonan K, Steinmetz R, Eugster EA, Levine MA, Pescovitz OH.
    J Pediatr; 2003 May 12; 142(5):532-8. PubMed ID: 12756386
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
    Perdigão PF, Pimenta FJ, Castro WH, De Marco L, Gomez RS.
    Int J Oral Maxillofac Surg; 2004 Jul 12; 33(5):498-501. PubMed ID: 15183415
    [Abstract] [Full Text] [Related]

  • 6. Fibrous dysplasia of bone and McCune-Albright syndrome.
    Chapurlat RD, Orcel P.
    Best Pract Res Clin Rheumatol; 2008 Mar 12; 22(1):55-69. PubMed ID: 18328981
    [Abstract] [Full Text] [Related]

  • 7. [Cellular and molecular biology of fibrous dysplasia].
    Marie P.
    Ann Pathol; 2001 Dec 12; 21(6):489-98. PubMed ID: 11910936
    [Abstract] [Full Text] [Related]

  • 8. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
    Shenker A, Weinstein LS, Sweet DE, Spiegel AM.
    J Clin Endocrinol Metab; 1994 Sep 12; 79(3):750-5. PubMed ID: 8077356
    [Abstract] [Full Text] [Related]

  • 9. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.
    Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S.
    J Clin Invest; 1996 Jul 01; 98(1):30-5. PubMed ID: 8690800
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.
    Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M.
    J Mol Diagn; 2000 May 01; 2(2):67-72. PubMed ID: 11272890
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.
    Candeliere GA, Glorieux FH, Prud'homme J, St-Arnaud R.
    N Engl J Med; 1995 Jun 08; 332(23):1546-51. PubMed ID: 7739708
    [Abstract] [Full Text] [Related]

  • 12. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
    Pollandt K, Engels C, Kaiser E, Werner M, Delling G.
    Virchows Arch; 2001 Aug 08; 439(2):170-5. PubMed ID: 11561757
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
    Stanton RP, Hobson GM, Montgomery BE, Moses PA, Smith-Kirwin SM, Funanage VL.
    J Bone Miner Res; 1999 Jul 08; 14(7):1104-14. PubMed ID: 10404010
    [Abstract] [Full Text] [Related]

  • 14. Bone morphogenetic proteins are expressed by both bone-forming and non-bone-forming lesions.
    Khurana JS, Ogino S, Shen T, Parekh H, Scherbel U, DeLong W, Feldman MD, Zhang PJ, Wolfe HJ, Alman BA.
    Arch Pathol Lab Med; 2004 Nov 08; 128(11):1267-69. PubMed ID: 15508192
    [Abstract] [Full Text] [Related]

  • 15. McCune-Albright syndrome: molecular genetics.
    Lumbroso S, Paris F, Sultan C.
    J Pediatr Endocrinol Metab; 2002 Nov 08; 15 Suppl 3():875-82. PubMed ID: 12199345
    [Abstract] [Full Text] [Related]

  • 16. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
    Leet AI, Chebli C, Kushner H, Chen CC, Kelly MH, Brillante BA, Robey PG, Bianco P, Wientroub S, Collins MT.
    J Bone Miner Res; 2004 Apr 08; 19(4):571-7. PubMed ID: 15005844
    [Abstract] [Full Text] [Related]

  • 17. Activating Gs a mutation rarely occurs in musculoskeletal tumors other than fibrous dysplasia.
    Gu W, Ogose A, Matsuba A, Kawashima H, Hotta T, Kudo N, Hoshino M, Kondo N, Mera H, Endo N.
    Anticancer Res; 2006 Apr 08; 26(2B):1611-4. PubMed ID: 16619580
    [Abstract] [Full Text] [Related]

  • 18. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.
    Lee SE, Lee EH, Park H, Sung JY, Lee HW, Kang SY, Seo S, Kim BH, Lee H, Seo AN, Ahn G, Choi YL.
    Hum Pathol; 2012 Aug 08; 43(8):1234-42. PubMed ID: 22245114
    [Abstract] [Full Text] [Related]

  • 19. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA, Ding C, Levine MA.
    J Bone Joint Surg Am; 2005 Nov 08; 87(11):2489-94. PubMed ID: 16264125
    [Abstract] [Full Text] [Related]

  • 20. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
    Sakamoto A, Oda Y, Oshiro Y, Tamiya S, Iwamoto Y, Tsuneyoshi M.
    Hum Pathol; 2001 Nov 08; 32(11):1245-51. PubMed ID: 11727265
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.